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INTRODUCTION 
 
        Rheumatoid arthritis (RA) is a chronic multisystem disease of unknown cause. The 
characteristic feature of RA is persistent inflammatory synovitis usually involving the 
peripheral joints in a symmetric fashion. The hallmark of the disease is cartilage damage 
and bone destruction1. Rheumatoid arthritis is the most common inflammatory arthritis, 
affecting 0.5% to 1% of general population worldwide. Because of its prevalence and 
ready accessibility of joint samples for laboratory investigation, rheumatoid arthritis has 
served as a useful model for the study of all inflammatory and immune mediated disease.  
 
        Rheumatoid arthritis patients can present with variety of clinical features, various 
articular and extra articular involvement. They may result in various complications which 
can impair the physical function in these patients. Pain in affected joints, aggravated by 
movement, is the most common manifestation of established RA.  Generalized stiffness is 
frequent and is usually greatest after periods of inactivity.    
  
        Rheumatoid arthritis does not involve the same type of joints in all patients. In 
general the number and severity of articular features vary with the duration and severity 
of the disease. Articular  manifestations(AM)  can  severely  affect  the  functional quality 
of an  individual  due  to various  deformities ,such as “Z” deformity, Swan neck 
deformity boutonnière deformity and hallux valgus1.    
 
        The Extra articular manifestations (EAM) may be due to formation of immune 
complexes. EAM includes the involvement of skin, eye, serosa, lung, heart, kidney, 
nervous system.  The extra articular manifestations also depend upon the duration of the 
disease. If the duration is more the severity is also more. EAM are also associated with 
excessive mortality, since they affect major organs.  
 
        In two-third of the patients, RA begins insidiously with constitutional symptoms 
such as fever, loss of appetite, fatigability and generalized weakness. This also makes the 
patients to abstain from day-to-day routine activities.  
                                                                   
                                                                
                
 
                       
                                           
 
 
 
 
AIM 
 
 
The aim of the study is: 
 
 
a) To identify and analyze the common presenting complaints of rheumatoid 
arthritis patients like loss of appetite, fever and fatigability. 
b) To assess the various joint involvement and extent of damage due to the 
disease process in patients with proven rheumatoid arthritis and it’s severity 
with the duration of the disease. 
c)  To document EAM in patients with proven rheumatoid arthritis and its 
significance with the duration and severity of the disease.  
d) To establish beneficial effects of disease modifying anti rheumatic drugs.  
                                                                        
 
 
 
 
 
 
                                                                            
 
 
 
 
 
 
 
                                         
 
                          
 
 
                         REVIEW OF LITERATURE 
 
 
 
MEDICAL HISTORY 
 
             Initial description of Rheumatoid arthritis made depressing reading indeed. SIR 
William Osler wrote:  
                   “ARTHRITIS DEFORMANS  
                     once established the disease is rarely curable. Too after it is a slow, but 
progressive crippling of the joints, with a disability that makes the disease one of the 
most terrible of human afflictions.” 
                                                                                          -W.Osler,1909  
 
         Medical historians disagree about the first references to Rheumatoid arthritis in lay 
and medical writings. Some have concluded that Rheumatoid arthritis described only 
recently as a clear cut entity, whereas others contrast that cause can be traced at least to 
1600’s. Sir Alfred Garrod, an English clinician and Geneticist first introduced the term 
Rheumatoid arthritis in 1876 to the description of symmetrical inflammatory arthritis. 
 
         Although the natural course of RA has changed minimally, the changing is in the 
understanding of pathophysiology and newer therapies that has become available. 
  
EPIDEMIOLOGY 
 
 
         Prevalence of RA in most population is around 1%, though there are a few 
exceptions. For instance in china, the incidence of RA is lower (0.3%) and substantially 
high in certain groups like Pima Indians in North America ( about 50%) whereas in India 
the prevalence is  0.6- 1%. 
 
Age 
 
  The incidence increases with age, and sex differences diminish in the older age 
group. The onset is most frequent during the fourth and fifth decades of life2, with 80% of 
all patients developing the disease between the ages of 35 and 50. The incidence of RA is 
more than six times greater than    in 60 to 64 year old women compared to 18-24 year 
old women. Recent data indicate that the incidence of RA may be diminishing1. 
 
Gender 
 
         The ratio of female to male patients is 2:1 to 4:1.The basis of this gender difference 
is probably due to the effect of the hormone milieu and immune function.  
  
 
ETIOLOGY AND PATHOGENESIS 
 
 
 
        Despite intensive work only modest progress has been achieved in determining the 
cause of RA. Clues have been provided by studies of immuno genetics of the Class II 
Major Histo compatibility complex loci and the usage of specific RF genes. The role of 
small molecule mediators of inflammation (e.g. Arachadonic acid metabolite), cytokines, 
growth factors, chemokines, adhesion molecules and matrix metallo proteinases (MMP’s) 
have been defined. 
        The etiology of RA is due to a blend of environmental and genetic factors.  
 
GENETIC FACTORS 
        Family studies indicate genetic predisposition. The highest risk of concordance of 
RA is noted in Twins who have two HLA-DRB1 alleles known to be associated with 
RA3. The most compelling evidence of genetic component is in monozygotic twins where 
the occurrence is 30 to 50 % when one twin is affected. 10% of patients with RA will 
have an affected first degree relative. 
       Pregnancy   is associated with remission of the disease in the last trimester4. 
Similarly, Oral contraceptives use shown decrease in severity of the disease5.           
 
 
  
HLA DR susceptibility  
 
        The structure of CLASS II surface molecules on antigen presenting cells is of great 
importance in the susceptibility and severity of RA. Initiation of certain T- Cells immune 
response is dependent in part on the presence or absence of particular MHC (DR) allelic 
products. The genetic link between HLA DR and RA is due to shared epitopes on the 
chains of DR that predispose to RA. The susceptibility epitopes are glutamine, leucine, 
arginine, alanine, and alanine- (QKRAA) a sequence found in HLA DR4 and DW16 
where RA is more prevalent. The DR4 β chains with greatest association with RA are DR 
β*0401, DR β*0101, and DRβ1*402. QKRAA epitope also predicts the severity of 
established RA.  
 
        HLA DR 2, DR 3, DR 5, DR 7 associations are protective against the development 
of RA. In Asian Indian and Israeli Jews HLA DR 1 (in stead of DR4) is associated with 
the development of RA. HLA DQ alleles, DQβ1*0301, *0302 are also associated with 
RA. Early aggressive disease is related to DR β*0401 and DR β, *0404. Slowly 
progressive disease is associated with DR β*0101. 
  
       The genes outside of the HLA complex also contribute to the development of RA. 
These include genes controlling the expression of the antigen receptor on T cells and both 
immunoglobulin heavy and light chains. 
Immunoglobulins 
        The class II MHC associations primarily implicate cellular immune response in RA. 
Deficient galactosylation of immunoglobulins is a risk factor for the development of RA. 
There is reduced galactosyl- transferase activity in RA β cells. 
Cytokine polymorphism and other genetic associations 
        Single nucleotide polymorphisms (SNP’s) in the promoter region or coding regions 
have been investigated in RA. The former could lead to altered gene regulations due to 
variable binding of transcription factors to promoters, while the latter directly changes the 
amino acid sequence of the encoded protein. 
 
      
 
        Several polymorphisms of the TNF- α promoter can alter gene transcription. 
Polymorphism of chemokines and inflammatory mediators like IL-1, CCR 5 and 
RANTES are associated with susceptibility. 
 
ENVIRONMENTAL  
 
 
         Smoking is clearly associated with development of RA. Several environmental 
stimuli, viruses including Retro viruses infect an individual with the appropriate genetic 
background and through some unknown mechanism the inflammatory response is 
focused in the joints. After gaining a toe – hold, there the synovitis persists because of 
local autoimmunity and other influences that enable the disease to become self 
perpetuating. 
 
        Epidemiologic studies in Africa have indicated that climate and urbanization have a 
major impact on the incidence and severity of RA in groups of similar genetic 
background.        
  
Infectious agents 
Infectious agents implicated are: 
a) Bacteria like protein and acinobactor 
b) Mycobacteria 
c) Mycoplasma and Chlamydia 
d) Borrelia Burdorferi 
e) Viruses 
         Ebstein Barr Virus has been indirectly implicated in the pathogenesis as well as the 
etiology of RA through the mechanism of molecular mimicry. Parvovirus B 19, Rubella, 
Cytomegalovirus and Lenti virus6 are also implicated in causing RA.  
        Chronic inflammatory response is produced by these organisms in the synovial 
tissues which lead to damage of the articular structures. The response to the micro 
organism might induce an immune response to components of the joint by altering its 
integrity and revealing antigenic peptides. 
 
 
 
 
 
 
 
 
PATHOGENESIS 
 
Auto immunity 
 
 
         RA is an autoimmune disease where synovial inflammation was mediated by local 
immune complex formation and complement consumption. 
 
        Rheumatoid Factor (RF) is an autoantibody reactive with the Fc portion of IgG, 
which is found in more than two-thirds of adults with the disease, and precedes the onset 
of RA by many years1. Some patients are initially sero negative and subsequently 
converted to seropositive which occurs during the first few years of the illness.  
         RA patients with positive test have severe clinical disease and complications than 
seronegative patients. RF is also able to fix and activate complement by the classic 
pathway. Large quantities of IgG RF are produced by rheumatoid synovial tissue and 
forms complexes through self association. The propagation of RA is an immunologically 
mediated event, although the original initiating stimulus has not been characterized. 
  
        RF containing immune complexes is readily detected in RA synovial tissue as well 
as surface layers of cartilage. Enhanced helper T- cell function has been correlated with 
the spontaneous production of RF of IgM type. Natural killer (NK) and Il-6 also have 
nonspecific B cell activation. IgM RF and IgG RF are the most abundant and pathogenic 
in RA followed by IgA RF. IgE RF has been demonstrated in a few cases.  
 
Autoimmunity to cartilage specific antigens 
        Certain joint specific antigens may play an etiologic or pathogenic role. 
They are  
 
A. Cartilage antigens 
     1. Type II Collagen 
     2. gp 39 
     3. Cartilage like protein 
     4. Proteoglycans 
     5. Aggrecans   
  
B. Other proteins 
 
      1. Citrullinated peptides 
      2. Glucose 6 phosphate Isomerase 
      3. Heat shock Proteins 
      4. Heavy chain binding proteins (BIP) 
      5. Super Antigens 
 
        Propagation of RA is an immunologically mediated event. Evidence for this 
includes: 
1. The predominance of CD4+ T cells in the synovium. 
2. Increase in IL-2 receptors, a product of activated T cells, in the blood and 
synovial fluid. 
3. Amelioration of the disease by removal of T cells by thoracic duct drainage. 
 
 
 
 
 
PATHOLOGY 
 
 
 
        The primary site of immune activation in RA is the synovium. Infiltration of 
synovium with mononuclear cells especially T- cells and macrophages and synovial 
intimal hyperplasia are the hallmarks of the disease. 
 
Synovial intimal lining 
 
 
        The synovial intimal lining in normal joint is 1-2 cell layers deep. Whereas in RA it 
is 4 -10 layers deep. Two major cells are found in the lining. They are a macrophage like 
cell known as Type A synoviocyte and a Fibroblast like cell called Type B synoviocyte.   
 
         There is absolute increase in both cell types in RA although the percentage increase 
in macrophage like cells is greater. PDGF, TGF β, TNF α and Il-1 along with 
Arachadonic acid metabolites induce proliferation of cells. Light microscopic 
examination of joint disclose hyperplasia and hypertrophy of the synovial lining cells, 
segmental vascular changes, thrombosis and neovascularization, edema and infiltration 
with mononuclear cells1. 
 
 
 
 
 
Synovial T- lymphocytes 
 
 
         In chronic RA the synovium contains a collection of t- Lymphocytes that resemble 
a lymphnode.The distribution varies from discrete lymphoid aggregate to diffuse sheets 
of mononuclear cells with the most predominant for T-cells along the perivascular region. 
These collections consists of small CD4 memory T-cells with scanty cytoplasm.  
 
         The presence of granulomatous lesions might be associated with EAM and products 
of both Th1 and Th2 cytokines in the synovium. T-cells consists 80% of cells in RA 
synovium and most are CD4 and 55 are B cells or plasma cells. The B cells are located 
primarily within reactive lymphoid centers whereas plasma cells and macrophages are 
often found outside the centers. This arrangement is consistent with T-cell dependent B 
lymphocyte activation. 
 
Synovial B lymphocytes 
 
         Synovial B-Lymphocytes and plasma cell hyperactivity are participants in the 
perpetuation and initiation of phases of RA. 
  
 
 
Other cell types 
 
        Dendritic cells are potent antigen presenting cells and are detected in synovial 
tissues and synovial effusions of patients with RA. NK cells and mast cells are also found 
in the synovial lining. Increased numbers of activated mast cells are also found in the 
Rheumatoid Synovium.  
 
T-cell Cytokines 
 
        Helper T-Cells has been divided into specific subsets. They are primarily Th1 and 
Th2 cells. Th1 associated cytokines are Interferon (IFN) γ, Interleukin IL-1 and Il-6 are 
implicated in RA.Th2 associated cytokines are IL-4, Il-5, IL-10, IL-17.Some produce 
both TNF α, Il-3 and Granulocyte Monocyte Colony stimulating factors (GMCSF). 
 
        Under production OF suppressor cytokines and Cytokines Antagonist like IL-4, IL-
10 and TNF β are also responsible for the synovial proliferation.  
  
        The activity of chemokines and cytokines appear to account for many of the features 
of rheumatoid synovitis including the synovial     tissue inflammation, synovial fluid 
inflammation, synovial proliferation and cartilage damage, as well as the systemic 
manifestation of RA. 
 
PDGF and fibroblast growth factor 
         Both are chemo tactic and mitogenic for fibroblast. It is the most potent stimulation 
of growth of synovial cells. 
 
Cartilage and bone destruction 
         RA cartilage is often covered by a layer of tissue composed of mesenchymal cells 
which might represent the progenitor of the aggressive mature pannus. In the established 
lesions numerous areas are seen in which macrophage like and fibroblast like cells 
penetrated into cartilage matrix. 
Cartilage is destroyed by both enzymatic and mechanical process. Matrix Metallo 
proteinases (MMP) are family of enzymes that participate in extra cellular matrix 
degradation and remodeling. MMP are collagenases, gelatinases, serine proteases and 
cathepsins. 
  
        Prostaglandin E2 produced by fibroblast and macrophages may also contribute to 
bone demineralization. Osteoclasts are also prominent at sites of bone erosion. 
Rheumatoid synovium is characterized by the presence of number of secreted products of 
activated lymphocytes, macrophages, and fibroblasts. Increased numbers of activated 
mast cells are also found in rheumatoid synovium.  
 
        Activated mesenchymal stromal cells, similar to those found in normal bone 
marrow, can sometimes also found in the rheumatoid synovium. 
 
         Increased number of a separate population of T cell found in the rheumatoid 
synovium. The major population of t cells composed of Cd4+ memory cells. Besides the 
accumulation of T cells, rheumatoid synovitis is also characterized by the infiltration of 
variable numbers of B cells and antibody producing plasma cells. 
 
           The synovial fibroblasts in RA manifest evidence of activation in that they 
produce lot of enzymes such as collagenases and cathepsins that can degrade the 
components of the articular matrix. 
  
CLINICAL FEATURES 
 
 
ONSET  
 
 
 
        The onset of symptoms is more frequent in winter than summer. Usually RA 
patients have insidious slow onset over weeks to months. Initial symptoms may be 
systemic or articular. Patients may present with fatigue, malaise, diffuse musculo skeletal 
pain, generalized weakness, fever, loss of appetite and in some cases with loss of weight 
also. May be first non specific complaints followed by articular manifestations.      
 
        In 10% of individuals, the onset is more acute, with a rapid development of 
polyarthritis often accompanied by constitutional symptoms including fever, 
lymphadenopathy, splenomegaly. Morning stiffness may appear before pain due to 
accumulation of edema fluid within the inflamed tissue during sleep and should persist at 
least 30-45 minutes before disappearing.  
 
      
 
         Joint pain predominantly originates from joint capsule which is abundantly supplied 
with pain fibers. Affected joint is held in flexed posture to maximize the joint volume to 
minimize the stretching of the capsule. Rheumatoid arthritis can affect any type of 
diarthrodial joint.   Symmetrical Joint involvement is due to bilateral release of 
neuropeptides (substance P) at terminal nerve endings in Joints.  
        Low grade fever and weight loss was seen in a few cases. A small percentage of 
patients present with an acute onset of the symptoms. 
 
 
Joint involvement 
 
 
        Most commonly involved joints are Metacarpophalangeal joint (MCP), Proximal 
interphalangeal joint (PIP), Metacarophalangeal joint (MTP) and wrists. Large joints such 
as elbow, hip, knee, and ankle   become symptomatic after the small joints. Cervical joint 
involvement and temporomandibular joint involvement also occur. In one study which 
was conducted in south India showed   significant involvement of temporomandibular 
joint. 
  
 
Involvement of specific joints  
 
Hand and wrist 
 
      Dorsal swelling on the wrist within the tendon sheath of the extensor muscle is one of 
the earlier sign of disease. As the synovial proliferation develops within the wrist 
integrity of the distal radio ulnar joint is lost. Ulnar head springs into distal prominence. 
 
        Hyper plastic synovia can compress the median nerve cause carpal tunnel syndrome 
often bilaterally. Progression of the disease is characterized by loss of joint space and 
bony ankylosis. Weakness of extensor carpi ulnaris leads to radial deviation of the wrist 
and ulnar deviation of the fingers (Zigzag deformity). 
 
        Swan neck Deformity is flexion of the DIP and MIP and hyperextension of the DIP 
joint due to shortening of the interosseous muscles and tendons. In chronic inflammation 
of PIP, Boutonnière Deformity occurs in which DIP joint is hyper extended.   
 
    
 
 
      In resorptive arthropathy there is severe disruption of bone that begins at the articular 
cartilage and spreads along the diaphysis of involved phalanges. Tenosynovitits of flexor 
tendon sheath is another common manifestation. Rheumatoid nodules may develop 
within the tendon sheaths and lock the fingers causing fixed flexion deformity. 
 
Elbow 
 
      Involvement of elbow is common in 20-68%, as the disease progresses disability can 
be severe. 
Shoulder 
 
     Involvement causes weakness of rotator cuff, chronic subacromial bursitis. Sterno 
clavicular and manubrio sternal joints are involved and cause symptoms in few cases. 
 
Crico Arytenoid Joints 
    Crico arytenoid joints may become inflamed and cause hoarseness of voice in some 
cases. Ossicles of the ear are rarely involved causing difficulty in hearing. 
  
Cervical spine 
 
        This is manifested as osteochondral destruction in RA. The atlantoaxial joint is 
prone to subluxation7. The earliest symptom is pain radiating to occiput. The clinical 
features are slowly progressive spastic quadri paresis and partial sensory loss in limbs. 
Transient episodes of medullary dysfunction are due to vertebral artery compression. 
Thoracic, lumbar and sacral spines are usually spared. 
 
Hip 
        Less frequently involved and presents as pain lower back or groin pain on lateral 
aspect of hip and it is due to trochanteric bursitis. 
 
Knees 
        Synovial inflammation and proliferation are common. Quadruceps atrophy is seen in 
few individuals. Popliteal or Baker’s cyst is also common. In few cases, chronic effusion 
and ligamental laxity were also seen in knee joint involvement. 
  
Ankle and Foot 
 
        Ankle involvement is rare. Achilles tendon nodules can develop & its spontaneous 
rupture can occur. Involvement of subtalar joint leads to Rocker Bottom foot. Metatarso 
phalangeal joints are commonly involved. Downward subluxation of metatarsal heads 
occur producing cock up toe deformity of PIP joints. Hallux Valgus, bunion or callus 
formation can occur. 
Other characteristic patterns of joint involvement are observed in 
 
         Adult onset still’s disease 
         Palindromic pattern8 
         Old age of onset above 60 years 
         Asymmetric disease 
         Arthritis Robustus 
      Felty’s syndrome consists of chronic RA, splenomegaly, neutropenia, and, on 
occasion, anemia and thrombocytopenia. These patients frequently have high titers of 
Rheumatoid factor, subcutaneous nodules, and other manifestations of systemic 
rheumatoid disease. 
  
EXTRA ARTICULAR MANIFESTATIONS OF RA (EAM) 
 
      In general the number and severity of EAM vary with the duration and severity of the 
disease. A number of these features may be related to extra articular foci of an immune 
response based on the evidence of independent and qualitatively different production of 
RA in the pleural space, pericardium, muscles and meninges. EAM of RA is associated 
with excess mortality9. 
 
1. Muscle 
 
    Degeneration of muscle fibers were found in all RA patients termed nodular mystics. 
There are 5 stages of muscle disease. 
 
     a) Diminution in muscle bulk with atrophy of type II fibers. 
     b) Peripheral mononeuropathy due to mononeuritis multiplex. 
     c) Steroid Myopathy 
     d) Active myositis and muscle necrosis 
     e) Chronic Myopathy 
  
 
 
2. Skin 
 
    The most frequent skin lesion in RA is rheumatoid nodules. The overlying skin of 
hands and finger become thin and atrophic. Palmar erythema is common. Raynolds 
phenomenon is rare. Evidence of vasculitis can range from nail fold infarcts to pyoderma 
gangrenosum. Palpable purpura and Livedo reticularis are due to deep dermal 
vasculopathy. 
 
3. Eye 
 
    Kerato conjunctivitis sicca is a component of Sjogren’s syndrome. Scleritis and 
episcleritis occur in less than 1% of RA. Tearing is due to gritty discomfort. There is no 
discharge. Secondary cataracts or keratitis can cause vision loss. Scleritis causes severe 
ocular pain and dark red discoloration. 
 
         It can be localized, generalized or necrotizing. Granulomatous resorption can cause 
scleromalacia perforans. Perilimbic ischemic ulcer can be cause by cryoproteins IgG 
complexes and results in perforation of anterior chamber. 
 
 
 
 
 
4. Rheumatoid nodules 
 
     It has a central core necrosis rimmed by corona of pallisading fibroblast which is 
surrounded by a collagenous capsule with perivascular collection of chronic 
inflammatory cells. The earliest nodules are less than 4 mm in size as the disease 
progresses, they increase in size. They are found in extensor surfaces e.g. over the 
olecranon and proximal tibia. They are also seen in occiput. Incidence is 20-35%10. They 
are subcutaneous, attached firmly to periostium, mobile and vary in consistency. 
 
    Rheumatoid nodule over the vocal cord cause progressive hoarseness. They can be 
found in the heart, lungs, sclera, leptomeniges, and vertebral bodies. RF is always found 
in serum of patients with rheumatoid nodules. Rarely nodules are present in the absence 
of obvious arthritis.  
 
     The presence of multiple nodules over the hands and a positive test for RF is 
associated with episodes of acute intermittent synovitis; subchondral cystic lesions of 
small bones of the hands and foot represent a condition called rheumatoid nodulosis.  
  
 
         Methotrexate therapy down regulates the synovitis but the existing nodules may 
enlarge and may increase in number1. 
 
Differential diagnosis of rheumatoid nodules is, 
 
            1. Benign nodules 
            2. Granuloma annulare 
            3. Xanthomatosis  
            4. Tophi 
            5. Miscellaneous- Yaws,Pinta, Leprosy, Basal cell   carcinoma,           
                                          Reticulo Histiocytosis. 
 
Fistula development 
       Fistula can develop in long standing RF positive patients. Cutaneuos sinuses near 
joints may develop. They are either sterile or septic. They usually connect the skin 
surface with a joint or with a bursa. 
  
 
6. Hematological abnormalities 
 
         The majority of patients with RA have mild normocytic normochromic anemia that 
correlated with ESR elevation and activity of the disease9. Three quarters of RA patients 
have anemia of chronic disease whereas one quarter will respond to iron therapy11. Both 
groups have superimposed vitamin B12 or folate deficiency. Anemia of chronic disease is 
associated with significantly higher ferritin concentration than in iron deficiency anemia. 
Folate and iron deficiency can mask iron deficiency by increasing MCV and MCHC. 
 
        ESR correlates inversely with hemoglobin levels. Erythropoietin levels are elevated 
in patients with iron deficiency than in anemia of chronic disease. Eosinophilia and 
thrombocytopenia are seen in RA. Eosinophilia (5% of TC) seen in patients with severe 
seropositive cases. Thrombocytosis is also seen in some payients12. 
 
      Some patients have increased number of large granular lymphocytes (LGL) in the 
peripheral blood, bone marrow, and liver. Paraproteinemia and monoclonal gammopathy 
has poor prognosis in RA patients.  
 
 
  
 
 
7. Vasculitis 
 
     Factors associated with increased incidence of vasculitis are13 
 
          a) Male gender 
          b) High titers of RF in serum 
          c) Joint erosions 
          d) Subcutaneous nodules 
          e) Circulatory cryoglobulins 
          f) Steroid therapy 
Clinical vasculitis manifest as  
          1. Distal arteritis- ranging from splinter hemorrhage to gangrene 
          2. Cutaneous ulceration 
          3. Peripheral neuropathy 
          4. Palpable purpura 
          5. Arteritis of viscera (e.g.) Heart, lungs, kidneys, liver spleen   
              pancreas & testes. 
 
 
  
 
         The pathologic finding in vasculitis is panarteritis14. All layers of vessel wall are 
infiltrated with mononuclear cells. Fibrinoid necrosis and intimal proliferation can 
predispose to thrombosis. The incidence is 1% and more common in men. Obliterative 
endarteritis of finger is one of the most common manifestations of vasculitis. 
 
8. Neuro vascular disease 
         This may be the only manifestations of vasculitis in some cases. 
     The few common clinical patterns are:  
               1. Mild distal sensory neuropathy 
               2. Severe sensory motor neuropathy 
      Symptoms of mild form are paraesthesia or burning feet and decreased touch and pain 
sensation distally. 
      Rheumatoid pachy meningitis is a rare complication of RA. Autonomic nervous 
disturbances can also occur. RA patients with vasculitis should be treated vigorously.  
  
 
9. Renal disease 
 
      Renal involvement is rare in RA. Drugs which are used in RA like salicylates and 
phenacetin can cause renal papillary necrosis. Membranous nephropathy is associated 
with gold salts and penicillamine. 
 
10. Pulmonary disease 
   There are six forms of the disease 
              1. Pleural disease 
              2. Interstitial fibrosis 
              3. Nodular lung disease 
              4. Bronchiolitis 
              5. Pulmonary hypertension 
              6. Small airway disease. 
a) Pleural disease 
This occurs in 20% of patients. Pleuritic pain is the main complaint. Effusion can be 
large enough to cause difficulty in breathing15. 
 
  
 
The characteristics of effusion are 
i. Low glucose910-50 mg/dl) 
ii. Protein >4g/dl 
iii. Cells are mononuclear  
iv. LDH is elevated 
v. CH50 decreased 
 
b) Interstitial Fibrosis and pneumonitis 
 
 
The increased activity of the mesenchymal cells in RA is the cause for pulmonary 
fibrosis. Clinical findings are fine, diffuse, dry rales. X-Ray shows diffuse reticular or 
reticulonodular pattern in both lung fields. HRCT shows lattice network. Smoking 
increases the risk. BAL shows increased number of lymphocytes. 
 
c) Nodular lung disease 
Nodules may be single or multiple. Single one is appears as coin lesions. Caplan’s 
syndrome is RA and pneumoconiosis16. Nodules may cavitate creating Brochopleural 
fistula. Malignant transformation to bronchogenic carcinoma is very rare17. 
  
d) Bronchiolitis 
It is a rare complication in RA patients. Proteinaceous exudate in bronchioles is 
characteristic18. It can cause respiratory insufficiency and death. 
e) Pulmonary Hypertension 
This occurs in 30% of patients. Most of them are asymptomatic. 
f) Small airway disease 
This occurs in 50% of RA patients. It is a part of generalized exocrinopathic process 
of the disease as in Sjogren’s syndrome19. 
11. Cardiac complications       
       Cardiac complication is due to granulomatous proliferation as vasculitis. 70% of 
modular patients and 40% non-nodular not patients have some cardiac involvement. 
a) Pericarditis 
     Pericardial involvement is seen in 50 % of patients at autopsy. 31% of RA had echo 
features of pericardial Effusion. Cardiac tamponade and constrictive pericarditis20 are 
rare.  Most of the patients are RF positive and half of them have nodules. 
  
b) Myocarditis 
     It may be granulomatous or interstitial myocarditis. Granulomatous process resembles 
subcutaneous nodules and specific for the disease.  
c)  Endocardial involvement like mitral regurgitation and aortic regurgitation are 
reported21.In some cases aortic valve regurgitation may be rapid22. 
d)  Conduction defects 
     AV Block, CHB is due to granulomatous involvement of AV node bundle of HISS. 
Rarely amyloidosis causes heart block. 
e)  Coronary Arteries 
      RA patients with vasculitis who develop myocardial infarction are likely to have 
coronary arteries involvement. 
12) Entrapment Neuropathy  
     RA patients develop entrapment neuropathy like carpal tunnel syndrome.  
DIAGNOSIS  
    Diagnosis is based on clinical examination / laboratory investigations and diagnosis 
that exclude it. Objective evidence of synovitis must be present for at least 6 weeks 
before the diagnosis. The diagnosis should be confirmed within two months after the 
onset of synovitis.  The diagnosis is confirmed only if the patients fulfill the American 
college of rheumatology (ACR) criteria. The following table clearly depicts the ACR 
guidelines.       
 
 
 
 
1987    REVISED AMERICAN RHEUMATOID ASSOCIATION CRITIRIA FOR 
DIAGNOSIS OF RHEUMATOID ARTHRITIS. 
 
 
 
 
CRITERION 
 
DEFINITION 
 
 
1.  Morning Stiffness 
 
Morning stiffness in and around the 
joints lasting at least 1 hour before 
maximal improvement 
 
2.  Arthritis of three or more joint  
     Areas 
 
At least three joint areas simultaneously 
having soft tissue swelling or fluid 
observed by a physician ( 14 possible 
joints are Right or Left PIP, MCP, 
Wrist, Elbow,  knee, Ankle and MTP 
joints) 
 
 
3.  Arthritis of hand joints 
 
At least one joint area swollen as above 
in Wrist, MCP or PIP joint 
 
4.  Symmetric Arthritis 
 
Simultaneous involvement  of the same 
joint areas on both sides of the body 
(bilateral involvement of PIP,  
MCP  or MTP joints is acceptable 
without absolute symmetry 
 
 
 
 
 
 
 
 
CRITERION DEFINITION 
5.   Rheumatoid Nodules Subcutaneous  nodules over bony 
prominences or extensor surfaces or in 
juxta articular regions observed by a 
physician 
6. Serum Rheumatoid factor Demonstrated by abnormal amounts of 
serum “Rheumatoid Factor” by any 
method  has been positive in less than 
5% of normal control subjects 
7.  Radiographic Changes Changes typical of RA on PA hand and 
wrist radiograph which must include 
erosions or unequivocal bony 
decalcification localized to or most 
marked adjacent to the involved joints. 
 
        A patient is said to have RA of she/he has satisfied at least four of the seven criteria.  
One to four must be present for at least 6 weeks. 
  
Laboratory Investigations 
1. Slight Leucocytosis with normal DC count.  
2. Thrombocytosis.  
3. Slight Anemia (Hb 10gm /dl) normochromic normocytic or microcytic.  
4. Normal Urine Analysis. 
5. ESR 30mm/hr or more. 
6. CRP > 0.7 pg/ml. 
7. Normal Renal, Hepatic, Metabolic function. 
8. Positive Rheumatoid factor test. 
9. Autoantibodies to flaggerin, Citrullinated proteins, calpastalin, components of 
splicesome (RA-33) and an unknown Ag Sa. 
10. ANA is positive in 40% of RA cases. 
11. Increased Alpha1 and Alpha 2 globulin. 
12. A normal or elevated serum complements level. 
  
13. Synovial fluid analysis. 
- Straw colored.  
- Clot Forms in fluid left. 
- 5000 to 25000 WBC/mm3 and 80% or polymorphs.  
- Complement levels C2 and C4 are decreased, C3 is normal 
- Glucose normal or reduced. 
14. High resolution ultra sonogram is useful in picking up early synovitis, effusion 
and erosions23. 
15. Magnetic resonance imaging of joints (MRI): It is also useful in detecting early 
RA23. 
16. Radiographic changes: X-ray hand and wrist radiographs show erosion and juxta-
articular osteoporosis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
 
 
 
        
      Patients with symptoms suggestive of Rheumatoid arthritis who represented the 
Medical OPD and Rheumatology OPD, Government Stanley medical college hospital 
during a period from July 2005 to June 2006 were included in this study. A total number 
of 100 patients who met the inclusion criteria below were included in this study. 
 
Inclusion Criteria: 
a. Patients who presented with typical clinical features based on the 
Modified American College of rheumatology criteria. 
b. Patients above 16 years of age. 
c. Patients already diagnosed to have RA  
Exclusion Criteria: 
a.   Patients with mono articular involvement. 
b.   Patients below 16 years 
c.   Patients who did not fulfilled the ACR criteria. 
  
        Patients who fulfilled the four of the seven criteria defined by the American College 
of Rheumatology (Modified ACR criteria) were included in the study. Detailed History 
of clinical features also obtained from the patients.  
 
      The RA patients thus selected were screened for various common clinical features, 
articular and extra articular manifestations using a structured Proforma designed for this 
study. 
 
      These patients were clinically examined   for evidence of articular and extra articular 
manifestations like   skin, skeletal, eye, serosal vascular, nervous and respiratory system 
involvement. 
      The patients on DMARDs also were included in the study to know the efficacy of 
these drugs in controlling the symptoms   
These patients were subjected to investigations: 
a. Hematological: Hb%, TC, DC, PCV, Peripheral smear study and platelet count. 
b. Acute phase reactants:  ESR, C - reactive protein. 
c. Urine analysis for sugar, protein & deposits. 
 
 
 
d. Immunological: Rheumatoid Factor and anti nuclear antibody. 
e. Metabolic: Renal function test (RFT), Liver function Test (LFT). 
f. Radiological: X- Ray chest, X-Ray hands & X- Ray of the involved     joints.                                       
g. Electrocardiogram (ECG): In relevant cases. 
 
 
h. Ultra sonogram (USG):  In selected patients. 
 
 
i. Echocardiography: In relevant cases. 
 
 
j. HRCT lung: In relevant   cases. 
 
 
 
       At the end of the study the proportion of articular and extra articular manifestations 
in 100 Rheumatoid arthritis patients screened were calculated and expressed as 
percentage. 
      The severity and frequency of these articular and extra articular manifestations were 
correlated with the duration of the illness and serological status.  
 
 
 
 
 
 
 
 
 
OBSERVATIONS AND RESULTS 
 
 
      A total number of hundred patients were included in this study in the age group 
ranging from 18-74years. The mean age is being 41.6 
1. The Total number of cases screened                            - 100 
2. Gender    
                        * No. of male RA patients screened            - 18 
                        * No. of female RA patients screened         - 82 
 
3.  Age group distribution of RA patients 
 
 
 
       Age 
 
              Males              Females 
      16-24 
 
                  3                     6 
      25-34 
 
                  2                   17 
      35-44 
 
                  4                   30 
  45and above 
 
                  9                   29 
 
 
4.  Sero Positivity – RF 
 
     
       RF POSITIVE  - 63 CASES 
 
          NEGATIVE – 37 CASES 
         MALE 
 
      FEMALE         MALE        FEMALE 
             7 
 
          56             11             26 
 
 
 
 
 
5. Clinical Features 
 
 
   1. Common constitutional symptoms observed were, 
 
 
SYMPTOMS MALE FEMALE TOTAL 
Fever 14 77 91 
Loss of weight 3 38 41 
Fatigability 9 43 52 
 
 
   2.  Articular Manifestations  
 
     The common articular manifestations observed were as follows: 
 
S.No 
 
Joints involved 
 
Percentage 
a)  Cervical Joint 3 % 
b)  Elbow 48 % 
c)  Wrist 82% 
d)  Hands(PIP&MCP) 100% 
e)  Hip 7% 
f)  Knee 7% 
g)  Ankle 45% 
h)  Foot (MTP&PIP) 37% 
  
3.   Extra Articular Manifestations (EAM) 
 
          The common EAM observed were as follows: 
 
S.no 
 
EAM 
 
Percentage 
a)  Anemia -20% 
b)  Rheumatoid Nodules  - 4% 
c)  Eye Involvement - 4% 
d)  Serosal Involvement  - 2% 
e)  Lung - 1% 
f)  Cardiac Involvement - 2% 
g)  Vasculitis -1% 
h)  Secondary Sjogren’s  - 4% 
i)  Neural   -1% 
 
 
 
8.  Duration of Symptoms and EAM 
 
      The extra articular manifestations with the duration of the disease observed were: 
 
Duration of 
Symptoms 
 0-2 years >2-5 years >  5 years 
 Male Female Male Female Male Female 
EAM 1 14 1 8 0 10 
 
 
 
                                               
 
   
 
 
DISCUSSION 
 
 
 
CONSTITUTIONAL SYMPTOMS 
 
 
      In this study three common symptoms such as Weight Loss, Fatigability and Fever 
were studied. 41 % of patients manifested with loss of weight and they have showed 
improvement in weight after starting the treatment. 
 
     Fatigability was observed in 91% of the patients.  In our OPD, majority of the RA 
patients presented with joint pain along with fatigue, which has incapacitated them from 
day to day activities. 
 
     Fever was present in 52% of patients diagnosed to have RA for the first time. Fever 
was also present when the patient gets acute attack of RA. 
 
ARTICULAR MANIFESTATIONS  
 
     The commonest joints involved are proximal inter phalangeal joints (PIP) and 
metacarpophalangeal (MCP) joints.  They are almost affected in all patients presented 
with RA.  For example a study conducted in south India (Chandrasekar, Radhakrishnan et 
al) 24, the involvement of PIP is 85%, MCP is 68% which shows the predilection for those 
joints in RA. The next common joint involved in wrist which was involved in 82% of RA 
patients.  
 
  
      The cervical joints are involved in three patients and among them one patient had it in 
the form of Atlanto axial subluxation. In a study conducted by D Chellapandian, C 
Rajendran Panchapakesa et al, showed 42% involvement of cervical spine25. 20% of them 
had Atlanto axial subluxation24, 25. The patient in this study was presented with gradual 
onset of quadriparesis. The other patients had cervical spine tenderness and limited 
mobility of cervical joint.    
 
     The other joints affected are 
 
           1. Elbow  -     48% 
           2. Hip  -       7% 
           3. Knee -     57% 
           4. Ankle        -       45% 
           5. Foot -     31% 
           6. TMJ          -       1%  
  
         Multiple joint involvements apart from upper limb joints are usually associated with 
chronic duration of the disease. The involvement of large joints occurred late. 
 
  
 
 
 
 EXTRA ARTICULAR MANIFESTATIONS 
 
 
  Anemia 
 
       In this study 22% of patients were manifested with anemia and 6 % of them were 
seronegative, whereas 16% cases were sero positive.   Normochromic Normocytic 
anemia was seen in 12 %.In varies studies the manifestation of anemia was in the range 
of 25-35%. 9, 11, 24 
    Hypochromic microcytic anemia was observed in 10%.Hemoglobin            levels are 
ranged from 7.5 – 8.5%.    
    
Rheumatoid nodules 
 
       Usually this occurs in 20 % to 30% of RA patients 9, 10.  In this study 4% of cases 
diagnosed to have rheumatoid   nodules.  Among them 3 were Sero positive and one was 
Sero Negative.  They were seen over the elbow. 
 
 Secondary SJOGREN’s 
      This can develop in 10-15%of long-term rheumatoid patients19. In    this study 
secondary Sjogren’s    was observed in 4% of    patients. 
  
Eye involvement 
      In this study, 4 patients showed evidence of Scleritis and episcleritis. 
 
Serosal involvement 
 
 
      Pleural involvement is normally seen in 20% of patients. In this study one patient 
showed pleural effusion and pericardial effusion was seen in one patient15. 
 
Pulmonary involvement 
 
 
      Interstitial lung disease was found in one patient who presented with dyspnoea and on 
examination had bilateral rales. Radiography showed Reticulonodular pattern and 
confirmed by HRCT. Pulmonary function test showed restrictive pattern. 
 
Cardiac involvement 
 
    Mitral valve prolapse and mild mitral regurgitation was seen in one patient and aortic 
regurgitation was seen in one patient. And it was confirmed with echocardiography.  
  
Vasculitis 
        Incidence of vasculitis is 1%. In this study one patient showed vasculitis feature and 
he was presented with cutaneuos ulcer in the legs.  It is usually seen in males. 
Neural involvement 
        In this study one patient presented with insidious onset of quadriparesis due to the 
compression of spinal cord, because of atlantoaxial subluxation.  
Response to Treatment  
            In this study, 85% of patients required disease modifying anti rheumatic drugs 
(DMARD) to control their symptoms and all of them had the disease for more than a year 
except for 3% of patients in whom the duration is less than 1 year. In a study conducted 
by Goldbach-Mansky R, Lipsky PE et al, it is shown that early institution of DMARDs is 
highly beneficial for patients with RA even at their first visit to rheumatologist26. Fifteen 
percentages of patients were not on DMARDs and the duration of the disease in them 
was less than a year. Patients who were on DMARD had a good pain relief and it has 
improved the functional quality of life in those patients.   
 
  
 
CONCLUSION 
 
1. Fatigability, Loss of weight and Fever were observed in 91%, 41% & 52% of 
patients respectively. 
 
2. All patients showed involvement of PIP& MCP joints. The next common joint 
involved was wrist in 82% of patients.  
 
3. Cervical joint involvement is seen in three patients and one of them had 
neurological deficit in the form of atlantoaxial subluxation resulting in 
quadriplegia. 
 
4. Extra articular manifestations (EAM) were found in 41%of patients studied. 
Among the EAM, anemia was the predominant manifestation and seen in 22% of 
patients.   
  
5. The frequency of complications was well correlated with duration of the disease. 
Those who were having the disease more than two years showed evidence of joint 
damage and extra articular manifestations.   
 
6. Majority of the patients with EAM were seropositive. And seropositive patients 
presented with joint damage earlier than seronegative patients. 
 
7. DMARD is required in 85% of patients to overcome the symptoms. 
 
 
 
 
 
 
BIBILIOGRPHY 
 
 
 
 
1. Kasper, Braunwald, Fauci, Hauser Peter e. Lipsky et al , authors of Harrison’s 
principles of internal medicine, 16 th edition, vol II: 1968-1977:2004.  
 
2. Abok, PalosuoJ, Rauniv V, et al: When does rheumatoid disease start? Arthritis 
Rheum 28: 485-489, 1985. 
 
3. Silman AJ, Macgreger AJ,Thomson , et al: Twin concordance rate for Rheumatoid 
arthritis: a nationwide study. Br J Rheumatol 32:903, 1953. 
 
4. Nelson JC, Voigt LF, Loepsell TD, et al: Pregnancy outcome in women in RA 
before disease onset. J.Rheumatol 19:18, 1982. 
 
5. Van Deber D, Hazes JMW, Vanderbrouche JP, et al: Diminished incidence of 
severe RA associated with OCP use. Arthritis Rheum 33:1462, 1990. 
 
6. Huskisson EC, Hart FD: Severe, unusual and recurrent infections in RA. Ann. 
Rheum Dis: 31: 118-121, 1972. 
 
 
 7. Collins DN, Barnes CL, Fitz Randolph RL et al: Cervical spine instability in RA 
patients having total hip or knee arthroplasty. Clin Orthop 272:127-135, 1991. 
 
8. Schumacher SR: Palindromic onset of RA, clinical, synovial fluid and biopsy 
studies. Arthritis rheum: 25: 361-369, 1982. 
 
9. Turesson g, O’Fallon WM, Crowson LS, et al: Occurrence of extra articular disease 
manifestations associated with excess mortality in a community based cohort of 
patients with RA. J Rheumatol 29:67-67, 2002. 
 
10. Ziff M: the rheumatoid nodule. Arthritis Rheum. 33:761-767,1990. 
 
11. Urengdenhil G, wognum AW, Van Eijk HG et al: Anemia in RA, the role of iron, 
Vitamin B12 and Folic Acid deficiency and Erythropoietin responsiveness.  Ann 
Rhema Dis 49:93-98, 1990. 
 
12. Farr M, Scott DL, Constable TJ, et al: Thrombocytosis of active rheumatoid 
disease. AM Rhem Dis 42:545; 549, 1983. 
 
 
 
 
 13. Voskuyl At, Zwisderonan AH, Westedt ML, et al: factors associated with the 
development of vasculitis in Rheumatoid arthritis: Results of a case-control study. 
AM Rheum Disc 55:190, 1996. 
 
14. Schind FR,Cooper NS, Ziff, et al: Arteritis in RA.AMJ med:30:56,1961. 
 
15. Dodson WH, Hollingsworth JW: Pleural Effusion in Rheumatoid Arthritis: 
impaired transport of glucose.N Engl  J. MEd.275:1337-1342, 1996. 
 
16. Tisher M. Grief J, Fireman E, et al: Bronchoalveolar lavage: a sensitive tool for 
early diagnosis of pulmonary involvement in RA. Br J Rheumatol B: 547-550, 
1986. 
 
17. Shenberger KN, Schned AR, Taylor TH: Rheumatoid disease and bronchogenic 
carcinoma: case report and review of the literature. Br J Rheumatol 11: 26-28, 
1984. 
 
18. S Jain, C Balakrishnan et al: follicular Bronchiolitis in a patient with Rheumatoid 
arthritis. J Indian Rheumatology assoc.2004:12:74-76.  
 
 
 
 19. Constantapoulos SH, Tsianos EV, Moustopoulos HM: Pulmonary and 
Gastrointestinal manifestations of Sjogren’s synd. Rheum Dis Clin North AM 
18:617-635, 1992.  
 
20. McRorie ER, Wright RA, Errington ML et al: Rheumatoid Constrictive Pericarditis. 
Br J Rheumatoid 36:100, 1997. 
 
21. Iveson JM, Thadani U, Ionesan M, etal: Aortic valve incompetence and 
replacement in RA. Ann-Rheum Dis 34:312-320, 1975. 
 
22. Camillesi JP, Douglas-Jones AG, Pritchard Mitt: Rapidly progressive aortic valve 
incompetence in a patient with RA. BR J Rheumatol 30:379-381, 1991. 
 
23. Wakefield RJ, McGonagle D, Green MJ et al. A comparison of high resolution 
sonography with MRI and conventional radiography for the detection of erosions in 
early Rheumatoid arthritis. J rheumatol 1998, 37(suppl):105. 
 
 
 
 
 
 
24. Chandrasekaran AN, Radhakrishnan B, Porkodi R et al: Spectrum of clinical & 
Immunological features of systemic Rheumatic disorders in a referral hospital in 
south India- Rheumatoid Arthritis. J Indian Rheumatology assoc. Vol.2 no1:18-26, 
1994. 
 
25. D Chellapandian, C Rajendran Panchapekesa et al: The cervical spine involvement 
in Rheumatoid arthritis and its correlation with disease activity. J Indian 
rheumatology assoc.2004:12:2-5. 
 
26. Goldbach-Mansky, Lipsky PE: New concepts in the treatment of Rheumatoid 
arthritis. Annu Rev Med 54:197, 2003. 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
CLINICAL PROFILE OF RHEUMATOID ARTHRITIS 
 
PROFORMA 
 
NAME                                                         AGE                          SEX 
 
OP/IP NUMBER                                         OCCUPATION 
 
ADDRESS 
 
 
PRESENTING COMPLAINTS: 
 
H/O PRESENTING ILLNESS: 
 
FAMILY HISTORY: 
 
PERSONAL HISTORY: 
 
PAST HISTORY: 
 
 
GENERAL EXAMINATION: 
 
 
 EXAMINATION OF JOINTS: 
 
SYSTEMIC EXAMINATION: 
   OPHTHALMIC 
   DERMATOLOGICAL 
CVS  
 
RS 
 
CNS 
 
MUSCLES 
 
GASTROINTESTINAL  
 
GENITOURINARY 
 
 
 
 
 
 
INVESTIGATION: 
 
URINE 
 
                  Albumin                 Sugar                           deposits 
 
HEMATOLOGY 
 
                  TC           DC          ESR           HB            Platelets. 
 
  Peripheral smear 
 
BLOOD CHEMISTRY: 
 
                  SUGAR              
                  LFT  
                  RFT    
                  Uric Acid. 
 
IMMUNOLOGICAL TESTS: 
 
                 RF  
                 CRP  
                 ASO  
                 ANA 
 
RADIOLOGY: 
 
                 X ray Chest PA view 
 
                 X ray hand and foot AP view in selected patients 
 
Others  
 
                 ECG 
 
                 Echocardiography 
                    
HRCT lung 
OTHER:                        
                       Summary of constitutional symptoms, articular manifestations and extra 
articular manifestations 
 
   
